The murine sarcoma virus-induced tumor: exception or general model in tumor immunology?
D000818:Animals; D000912:Antibodies, Neoplasm; D000914:Antibodies, Viral; D000917:Antibody Formation; D000951:Antigens, Neoplasm; D000956:Antigens, Viral; D002213:Capsid / Q000276:immunology; D002462:Cell Membrane / Q000276:immunology; D002471:Cell Transformation, Neoplastic; D003673:Defective Viruses / Q000276:immunology; D000939:Epitopes; D017988:Gammaretrovirus / Q000276:immunology*; D006378:Helper Viruses / Q000276:immunology; D006649:Histocompatibility Antigens; D007109:Immunity; D007111:Immunity, Cellular; D007165:Immunosuppression Therapy; D007942:Leukemia, Experimental / Q000209:etiology / Q000276:immunology; D008214:Lymphocytes / Q000276:immunology; D051379:Mice; D009368:Neoplasm Transplantation; D009053:Sarcoma Viruses, Murine / Q000276:immunology*; D012513:Sarcoma, Experimental / Q000209:etiology / Q000276:immunology*; D014412:Tumor Virus Infections / Q000276:immunology
D000912:Antibodies, Neoplasm; D000914:Antibodies, Viral; D000951:Antigens, Neoplasm; D000956:Antigens, Viral; D000939:Epitopes; D006649:Histocompatibility Antigens